Diabetes and the Cardiometabolic Continuum

(P100) A Population Health Approach to Implementing DSMT Services in a Hospital-Based Setting

(P101) Adherence and Persistence to Oral Semaglutide versus DPP-4is Among People with T2D in a US Real-World Setting

(P102) Adverse Effects in Older Patients with T2D Treated with SGLT2 Inhibitors

(P103) Diabetes Affects Men and Women Differently: A Review of the Evidence

(P104) Diabetes and Periodontitis: What Are We Missing in Diabetes Care to Improve Outcomes?

(P106) Hypoglycemia Documentation in a Large Teaching Hospital

(P107) Implementing a Prediabetes Screening Algorithm in the Primary Care Setting

(P108) Insulin Simulator: Demystifying How Insulin Impacts Glucose in Real Time

(P109) NAFLD Updates: What Diabetes Care and Education Specialists Need to Know

(P110) Outcomes with Finerenone in People with CKD and T2D by Baseline Insulin Resistance: A FIDELITY Subgroup Analysis

(P111) Perceived Health Risks and Healthy Behavior Intentions Among Low-Income Postpartum Women with Recent Gestational Diabetes

(P112) Self-management Counseling to Reduce Cardiometabolic Risk for T2D in Reproductive Age Women: A Survey of Primary Care Practices

(P113) Relationship Between Body Weight Change and Glycemic Control with Tirzepatide Treatment in People with Type 2 Diabetes

(P114) Prevalence of Chronic Kidney Disease Associated With T1D in the US

(P115) Real World Experiences of Patients Using Oral Semaglutide for T2D

(P116) Real-World Effectiveness of Once-Weekly Semaglutide in Glycemic Control and Weight Outcomes in Type 2 Diabetes

(P117) Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1 RAs) on Glycemic Control and Weight Outcomes in Type 2 Diabetes

(P118) REal-World Impact of Once-Weekly Injectable Semaglutide on GLycemic Control and Weight Outcomes Based on Highest Dose Received and Persistence With Treatment in Type 2 DiAbeTEs (RELATE – OW Injectable Semaglutide)

(P119) REal-World Impact of Oral Semaglutide on GLycemic Control and Weight Outcomes Based on Highest Dose Received and Persistence With Treatment in Type 2 DiAbeTEs (RELATE – Oral Semaglutide)

(P120) Peripheral Diabetes-Related Neuropathy: It's a Pain

(P121) The Association Between Avocado Consumption and Diabetes: Results From Encuesta Nacional de Salud y Nutrición (ENSANUT)

(P122) The Impact of Drug Therapy Management by Pharmacists on Glycemic Management in Patients with Diabetes: A Systematic Review

(P124) Tray Talk: Increasing RN Meal Pattern Discussions for People with Diabetes

(P128) Understanding Patient Receptivity Towards Receipt of Prognostic Risk Score for Diabetic Kidney Disease

(P129) Updates on Dyslipidemia Management in Diabetes: From Guidelines to Novel Therapies